The human one
β-MSH (beta-melanocyte-stimulating hormone): the POMC peptide tied to human appetite
β-MSH is a broad-spectrum melanocortin cut from POMC. Its standout feature is species-specific: humans make it in the brain and rodents largely don't, which puts β-MSH at the centre of translating melanocortin appetite biology to people.
The verse of the system that speaks loudest in humans — a melanocortin the mouse mostly skips, and a reminder the map is redrawn in people.
β-MSH — beta-melanocyte-stimulating hormone — is one of the quieter members of the melanocortin family, but it carries an outsized lesson about why this system matters in people specifically. Like α-MSH, it is a broad-spectrum agonist cut from POMC. Unlike α-MSH, its story is largely a human one.[2]
A broad-spectrum POMC peptide
β-MSH is produced by the same POMC processing that yields the other melanocortins, and its receptor activity looks familiar: agonism across MC1R, MC3R, MC4R, and MC5R.[1]In that sense it is another copy of the broad melanocortin signal, overlapping heavily with α-MSH rather than carving out a distinct receptor niche.
The human-specific twist
What makes β-MSH worth its own page is a quirk of species. Humans generate β-MSH in the brain as part of their melanocortin appetite machinery; the mice and rats that most melanocortin research is done in largely do not.[1] That gap is easy to overlook and important to remember: a satiety signal that is real in people can be effectively absent in the standard animal model, which is one reason melanocortin appetite findings do not always translate cleanly across species.
Because β-MSH contributes to the human MC4R "fullness" signal, it also shows up in the genetics of body weight. Rare variants that impair β-MSH production or function have been associated with obesity in people — the same direction of effect seen when any part of the MC4R pathway is weakened.[1]
The honest bottom line
β-MSH is a reminder that the melanocortin system is not identical from one species to the next. Its broad receptor activity makes it look like a second α-MSH, but its human-specific role in appetite gives it a distinct place in the story — and a cautionary note for anyone reading mouse data as if it were human data. For the receptor at the centre of that appetite signalling, see MC4R — the appetite rheostat.
Education, not medical advice
This page explains the biology of a natural signalling peptide. It is not a description of any product or treatment, and it is not medical advice. See the editorial standards.
Common questions
What is β-MSH?
Beta-melanocyte-stimulating hormone (β-MSH) is one of the melanocortin peptides cut from the POMC precursor. Like α-MSH, it is a broad-spectrum agonist across the pigment and appetite receptors, and in humans it is a meaningful part of the brain’s melanocortin appetite signalling.
How is β-MSH different from α-MSH?
They are close relatives with overlapping activity — both activate MC1R, MC3R, MC4R, and MC5R. The most interesting difference is species-specific: humans produce β-MSH in the brain, whereas common lab rodents do not, which makes β-MSH particularly relevant when translating melanocortin appetite biology to people.
Is β-MSH linked to obesity?
There is evidence pointing that way. Because β-MSH contributes to the human melanocortin satiety signal at MC4R, rare variants that impair its production or function have been associated with obesity in people — consistent with the broader theme that weakening MC4R signalling promotes weight gain.